Physician profile
Ryan Gifford
NPI 1295996627
$14,271.51
in general payments reported to CMS, 2019-2025
6 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,773 · 2020: $680 · 2021: $1,711 · 2022: $839 · 2023: $1,412 · 2024: $575 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Entertainment: $902 · Education: $257 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27.35 · Gift: $26.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.07 |
| Entertainment | $901.98 |
| Education | $257.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27.35 |
| Gift | $26.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $9,500.69 | 2019-2023 | Nobelactive |
| Straumann USA LLC | $3,354.64 | 2019-2025 | |
| Keystone Dental INC. | $1,279.82 | 2022-2024 | |
| Biohorizons Implant Systems INC. | $89.80 | 2023-2024 | Biohorizons |
| Geistlich Pharma, North America, INC. | $30.93 | 2020 | |
| Orapharma, A Division of Bausch Health US, LLC | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Gifford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.